VSI - Vitamin Shoppe, Inc.

NYSE - NYSE Delayed Price. Currency in USD
4.1300
-0.0500 (-1.20%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close4.1800
Open4.1500
Bid4.1300 x 800
Ask4.1400 x 900
Day's Range4.0300 - 4.2400
52 Week Range3.3200 - 13.9500
Volume238,361
Avg. Volume582,487
Market Cap97.197M
Beta (3Y Monthly)2.27
PE Ratio (TTM)26.99
EPS (TTM)0.1530
Earnings DateAug 6, 2019 - Aug 12, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.00
Trade prices are not sourced from all markets
  • Can 2020 Strategy Aid Clorox Despite Soft View & High Costs?
    Zacks4 days ago

    Can 2020 Strategy Aid Clorox Despite Soft View & High Costs?

    Clorox (CLX) focuses on 2020 Strategy and digital efforts, as it faces the brunt of muted FY19 view.

  • United Natural (UNFI) Q3 Earnings Beat Estimates, Sales Miss
    Zacks11 days ago

    United Natural (UNFI) Q3 Earnings Beat Estimates, Sales Miss

    United Natural's (UNFI) earnings top estimates while sales lag the same in third-quarter fiscal 2019. Also, management issued a drab view for the fiscal year.

  • Is Vitamin Shoppe (VSI) Stock Undervalued Right Now?
    Zacks12 days ago

    Is Vitamin Shoppe (VSI) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Thomson Reuters StreetEvents12 days ago

    Edited Transcript of VSI earnings conference call or presentation 8-May-19 12:30pm GMT

    Q1 2019 Vitamin Shoppe Inc Earnings Call

  • PR Newswire18 days ago

    The Vitamin Shoppe® Announces Participation At Investor Conference

    SECAUCUS, N.J. , May 30, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer of nutritional products, today announced management's participation at Baird's 2019 Consumer, ...

  • PR Newswire19 days ago

    The Vitamin Shoppe Expands CBD Hemp Extract Offerings to 390 Stores, 31 States

    SECAUCUS, N.J., May 29, 2019 /PRNewswire/ -- The Vitamin Shoppe (VSI), an omni-channel specialty retailer of nutritional products, is continuing to expand its CBD hemp extract offerings to meet consumer demand and serve as a trusted retailer of quality health and wellness supplements.  The Company is now a one-stop destination for CBD hemp extract, with 390 stores in 31 states offering a variety of product forms, including soft gels, aromatherapy oils, liquid drops for humans and dogs, and a forthcoming rollout of CBD natural beauty products. The Vitamin Shoppe launched a full line of CBD hemp extract essential oils by SpaRoom in March and followed up on its success in April with the introduction of Irwin Naturals Full Spectrum Hemp Extract soft gels and Garden of Life Dr. Formulated Broad Spectrum CBD hemp extract liquid drops, which includes a variation for adult dogs.

  • Top Ranked Value Stocks to Buy for May 15th
    Zackslast month

    Top Ranked Value Stocks to Buy for May 15th

    Top Ranked Value Stocks to Buy for May 15th

  • Is Vitamin Shoppe (VSI) a Great Value Stock Right Now?
    Zackslast month

    Is Vitamin Shoppe (VSI) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Associated Presslast month

    Vitamin Shoppe: 1Q Earnings Snapshot

    The Secaucus, New Jersey-based company said it had net income of 15 cents per share. Earnings, adjusted for non-recurring costs, were 21 cents per share. The nutritional supplement retailer posted revenue ...

  • PR Newswirelast month

    Vitamin Shoppe, Inc. Announces First Quarter 2019 Results

    First Quarter 2019 Highlights: - Gross Profit Margin Increases 200 basis points - Total Comparable Sales (3.5%) - GAAP net earnings per share from continuing operations of $0.15 . Adjusted net earnings ...

  • How Vitamin Shoppe (VSI) Looks Just Ahead of Q1 Earnings
    Zackslast month

    How Vitamin Shoppe (VSI) Looks Just Ahead of Q1 Earnings

    Soft store comps are likely to hurt Vitamin Shoppe's (VSI) top line in Q1. However, the company's strategic efforts to enhance its store and online experience may provide a cushion to the stock.

  • PR Newswire2 months ago

    Vitamin Shoppe, Inc. Announces Fiscal First Quarter 2019 Earnings Release and Webcast Date

    SECAUCUS, N.J., April 25, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (VSI), an omni-channel, specialty retailer of nutritional products, today announced that the Company will release its fiscal first quarter 2019 financial results before the market opens on Wednesday, May 8, 2019.  A conference call will be webcast the same day beginning at 8:30 a.m. Eastern Time.  The call can be accessed by dialing 1-888-394-8218 or for international callers, 1-323-701-0225.  The passcode is 7183793. Interested investors and other parties may listen to the webcast of the conference call by visiting the Investor Relations section of the Company's website at www.vitaminshoppe.com and clicking on the webcast link. A telephonic replay will be available for one week following the call beginning at 11:30 a.m. Eastern Time on May 8, 2019 and ending on May 15, 2019 at 11:59 p.m. Eastern Time.  The replay can be accessed by dialing 1-844-512-2921 or for international callers, 1-412-317-6671.  The passcode for the replay is 7183793.  The webcast will also be archived on the Company's website at www.vitaminshoppe.com in the investor relations section.

  • CNBC2 months ago

    Vitamin Shoppe to sell edible CBD supplements as consumers clamor for cannabis compound

    The Vitamin Shoppe is now started stocking its shelves with CBD soft gels. Vitamin Shoppe will add CBD drops later this month. CVS, Walgreens and Rite Aid all recently said they would carry CBD-infused products in some states.

  • 7 Rewarding Low Price-to-Sales Stocks to Buy Right Away
    Zacks2 months ago

    7 Rewarding Low Price-to-Sales Stocks to Buy Right Away

    Price-to-sales has emerged as a convenient tool to determine the value of stocks that are incurring losses or are in an early cycle of development, generating meager or no profits.

  • PR Newswire2 months ago

    The Vitamin Shoppe Launches New Healthy Awards® Loyalty Program Nationwide

    SECAUCUS, N.J., April 8, 2019 /PRNewswire/ -- The Vitamin Shoppe® (VSI), an omni-channel specialty retailer of nutritional products, announced today that its new and improved Healthy Awards® loyalty program launched nationwide after a successful pilot. The program is designed to empower The Vitamin Shoppe customers to make their well-being a priority and live their best life, however they define it. Sharon Leite, Chief Executive Officer of The Vitamin Shoppe said, "The customer relationship is the cornerstone of The Vitamin Shoppe's reinvention.

  • Vitamin Shoppe (VSI) Stock Sinks As Market Gains: What You Should Know
    Zacks2 months ago

    Vitamin Shoppe (VSI) Stock Sinks As Market Gains: What You Should Know

    Vitamin Shoppe (VSI) closed at $7.24 in the latest trading session, marking a -0.07% move from the prior day.

  • Is Vitamin Shoppe (VSI) Stock Outpacing Its Retail-Wholesale Peers This Year?
    Zacks2 months ago

    Is Vitamin Shoppe (VSI) Stock Outpacing Its Retail-Wholesale Peers This Year?

    Is (VSI) Outperforming Other Retail-Wholesale Stocks This Year?

  • Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final
    Zacks2 months ago

    Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final

    Zacks.com featured highlights include: G-III, Vitamin Shoppe, Tech Data and Smart & Final

  • Zacks Small Cap Research2 months ago

    MYOS: Yolked, MYOS Canine Formula Sales Accelerating. Going Into 2019 w/ New Clinical Evidence and Marketing Initiatives

    MYOS RENS Technology (MYOS) reported Q4’18 financial results and provided a business update. Revenue from both Yolked and MYOS Canine Muscle Formula, their two lead products which launched in April and June (2018), respectively, reached new quarterly highs in the period.

  • Pick These 5 Bargain Stocks With Enticing EV/EBITDA Ratios
    Zacks2 months ago

    Pick These 5 Bargain Stocks With Enticing EV/EBITDA Ratios

    We have screened bargain stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.

  • Reuters3 months ago

    J.C. Penney appoints Vitamin Shoppe's Bill Wafford as CFO

    Department store operator J.C. Penney Co Inc on Tuesday named Bill Wafford chief financial officer, ending the struggling retailers months-long search. Wafford will take charge on April 8, succeeding interim ...

  • MarketWatch3 months ago

    J.C. Penney shares gain after department store operator recruits Vitamin Shoppe CFO

    Shares of J.C. Penney Co. rose in Tuesday's extended session after the department store operator said it has appointed Bill Wafford as its chief financial officer, effective April 8. Wafford most recently was the financial chief at Vitamin Shoppe Inc. . The nutritional products company, meanwhile, named Charles Knight, previously of Toys R Us, as its interim CFO. J.C. Penney shares were up 1.3% and Vitamin Shoppe shares slid more than 4%.

  • PR Newswire3 months ago

    The Vitamin Shoppe® Announces Chief Financial Officer Resignation

    -- PROMOTES CHARLES KNIGHT AS INTERIM CHIEF FINANCIAL OFFICER SECAUCUS, N.J. , March 26, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI) (the "Company"), an omni-channel, specialty retailer ...

  • Zacks3 months ago

    Stocks Jump on Delayed Reaction to Fed News

    Stocks Jump on Delayed Reaction to Fed News

  • Invest Carefully Despite a Dovish Fed: 5 Safe Picks
    Zacks3 months ago

    Invest Carefully Despite a Dovish Fed: 5 Safe Picks

    The Fed has also reduced the growth projection of U.S. GDP, while raising its previous projection for unemployment.